249 related articles for article (PubMed ID: 12894135)
1. Combining the new biologic agents with our current psoriasis armamentarium.
Lebwohl M
J Am Acad Dermatol; 2003 Aug; 49(2 Suppl):S118-24. PubMed ID: 12894135
[TBL] [Abstract][Full Text] [Related]
2. Combining traditional agents and biologics for the treatment of psoriasis.
Cather JC; Menter A
Semin Cutan Med Surg; 2005 Mar; 24(1):37-45. PubMed ID: 15900797
[TBL] [Abstract][Full Text] [Related]
3. Advancements in the treatment of psoriasis: role of biologic agents.
Rich SJ; Bello-Quintero CE
J Manag Care Pharm; 2004; 10(4):318-25. PubMed ID: 15298530
[TBL] [Abstract][Full Text] [Related]
4. Combining biologic therapies with other systemic treatments in psoriasis: evidence-based, best-practice recommendations from the Medical Board of the National Psoriasis Foundation.
Armstrong AW; Bagel J; Van Voorhees AS; Robertson AD; Yamauchi PS
JAMA Dermatol; 2015 Apr; 151(4):432-8. PubMed ID: 25517130
[TBL] [Abstract][Full Text] [Related]
5. Treatments for psoriasis and the risk of malignancy.
Patel RV; Clark LN; Lebwohl M; Weinberg JM
J Am Acad Dermatol; 2009 Jun; 60(6):1001-17. PubMed ID: 19344980
[TBL] [Abstract][Full Text] [Related]
6. Biologic therapy for psoriasis--the first wave: infliximab, etanercept, efalizumab, and alefacept.
Weinberg JM; Saini R; Tutrone WD
J Drugs Dermatol; 2002 Dec; 1(3):303-10. PubMed ID: 12851990
[TBL] [Abstract][Full Text] [Related]
7. Systemic therapies for psoriasis: understanding current and newly emerging therapies.
Sobell JM; Hallas SJ
Semin Cutan Med Surg; 2003 Sep; 22(3):187-95. PubMed ID: 14649586
[TBL] [Abstract][Full Text] [Related]
8. European S3-guidelines on the systemic treatment of psoriasis vulgaris.
Pathirana D; Ormerod AD; Saiag P; Smith C; Spuls PI; Nast A; Barker J; Bos JD; Burmester GR; Chimenti S; Dubertret L; Eberlein B; Erdmann R; Ferguson J; Girolomoni G; Gisondi P; Giunta A; Griffiths C; Hönigsmann H; Hussain M; Jobling R; Karvonen SL; Kemeny L; Kopp I; Leonardi C; Maccarone M; Menter A; Mrowietz U; Naldi L; Nijsten T; Ortonne JP; Orzechowski HD; Rantanen T; Reich K; Reytan N; Richards H; Thio HB; van de Kerkhof P; Rzany B
J Eur Acad Dermatol Venereol; 2009 Oct; 23 Suppl 2():1-70. PubMed ID: 19712190
[TBL] [Abstract][Full Text] [Related]
9. Biologics combined with conventional systemic agents or phototherapy for the treatment of psoriasis: real-life data from PSONET registries.
Busard CI; Cohen AD; Wolf P; Gkalpakiotis S; Cazzaniga S; Stern RS; Hutten BA; Feldhamer I; Quehenberger F; Lichem R; Kojanova M; Adenubiova E; Addis A; Naldi L; Spuls PI
J Eur Acad Dermatol Venereol; 2018 Feb; 32(2):245-253. PubMed ID: 28898541
[TBL] [Abstract][Full Text] [Related]
10. Integrating biologic agents into management of moderate-to-severe psoriasis: a consensus of the Canadian Psoriasis Expert Panel. February 27, 2004.
Guenther L; Langley RG; Shear NH; Bissonnette R; Ho V; Lynde C; Murray E; Papp K; Poulin Y; Zip C
J Cutan Med Surg; 2004; 8(5):321-37. PubMed ID: 15868311
[TBL] [Abstract][Full Text] [Related]
11. An attempt to formulate an evidence-based strategy in the management of moderate-to-severe psoriasis: a review of the efficacy and safety of biologics and prebiologic options.
Leon A; Nguyen A; Letsinger J; Koo J
Expert Opin Pharmacother; 2007 Apr; 8(5):617-32. PubMed ID: 17376017
[TBL] [Abstract][Full Text] [Related]
12. Biologic and Conventional Systemic Therapies Show Similar Safety and Efficacy in Elderly and Adult Patients With Moderate to Severe Psoriasis.
Garber C; Plotnikova N; Au SC; Sorensen EP; Gottlieb A
J Drugs Dermatol; 2015 Aug; 14(8):846-52. PubMed ID: 26267729
[TBL] [Abstract][Full Text] [Related]
13. Comparative tolerability of systemic treatments for plaque-type psoriasis.
McClure SL; Valentine J; Gordon KB
Drug Saf; 2002; 25(13):913-27. PubMed ID: 12381213
[TBL] [Abstract][Full Text] [Related]
14. Treatment of psoriasis and psoriatic arthritis.
Papoutsaki M; Costanzo A
BioDrugs; 2013 Jan; 27 Suppl 1():3-12. PubMed ID: 23990277
[TBL] [Abstract][Full Text] [Related]
15. Psoriasis: current perspectives with an emphasis on treatment.
Linden KG; Weinstein GD
Am J Med; 1999 Dec; 107(6):595-605. PubMed ID: 10625029
[TBL] [Abstract][Full Text] [Related]
16. Systemic therapy for psoriasis.
Lee M; Kalb RE
Dermatol Nurs; 2008 Apr; 20(2):105-11; quiz 112. PubMed ID: 18549125
[TBL] [Abstract][Full Text] [Related]
17. A treatment strategy for psoriasis: transitioning from systemic therapy to biologic agents.
Ortiz A; Yamauchi PS
Skinmed; 2006; 5(6):285-8. PubMed ID: 17085995
[TBL] [Abstract][Full Text] [Related]
18. Chronic plaque psoriasis.
Naldi L; Rzany B
Clin Evid; 2006 Jun; (15):2249-83. PubMed ID: 16973087
[No Abstract] [Full Text] [Related]
19. [Biologics in the treatment of psoriasis].
Dissemond J; Grabbe S
MMW Fortschr Med; 2006 Sep; 148(38):42-4. PubMed ID: 17036963
[TBL] [Abstract][Full Text] [Related]
20. Economic evaluation of systemic therapies for moderate to severe psoriasis.
Sizto S; Bansback N; Feldman SR; Willian MK; Anis AH
Br J Dermatol; 2009 Jun; 160(6):1264-72. PubMed ID: 19120346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
